Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda
Abstract Background Injectable artesunate (AS) is the World Health Organization (WHO) recommended medication for the treatment of severe malaria followed with an oral artemisinin-based combination therapy (ACT). There are few studies indicating how physicians prescribe injectable AS, injectable quin...
Main Authors: | H. Hilda Ampadu, Kwaku Poku Asante, Samuel Bosomprah, Samantha Akakpo, Pierre Hugo, Helga Gardarsdottir, Hubert G. M. Leufkens, Dan Kajungu, Alexander N. O. Dodoo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-019-2670-9 |
Similar Items
-
Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria
by: Qigui Li, et al.
Published: (2010-07-01) -
Prescribing practice of long-acting injectable antipsychotics
by: Jisha M Lucca, et al.
Published: (2020-01-01) -
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
by: Rouamba T, et al.
Published: (2019-02-01) -
Level of knowledge among health care providers on preparation of injectable artesunate for treatment of severe malaria in public health facilities in Tanzania
by: Wigilya P. Mikomangwa, et al.
Published: (2019-04-01) -
Temperature changes in the course of treatment of severe malaria patients with artemether and quinine
by: AA Osonuga
Published: (2011-05-01)